GenadyneBiotechnologies|EN(V5.0909.1) 7
PatientSizeandWeight
The size and weight of the patient should be considered when prescribing Genadyne XLR8 Therapy.
Infants, children, certain small adults and elderly patients should be closely monitored for fluid loss
and dehydration. Also, patients with highly exudating wounds or large wounds in relation to the
patient size and weight should be closely monitored, as they may have a risk of excessive fluid loss
and dehydration. When monitoring fluid output, consider the volume of fluid in both the tubing and
canister.
SpinalCordInjury
In the event a patient experiences autonomic hyperreflexia (sudden elevation in blood pressure or
heart rate in response to stimulation of the sympathetic nervous system), discontinue Genadyne
XLR8 Therapy to help minimize sensory stimulation and seek immediate medical assistance.
Bradycardia
To minimize the risk of bradycardia, the Genadyne XLR8 Therapy dressing must not be placed in
proximity to the vagus nerve.
EntericFistulas
Wounds with enteric fistulas require special precautions to optimize Genadyne XLR8 Therapy. In
certain circumstances, the Genadyne XLR8 Therapy may help to promote healing in wounds with an
enteric fistula. When the physician orders the Genadyne XLR8 Therapy, it is recommended that
support from an expert clinician is sought. Genadyne XLR8 Therapy is not recommended or
designed for fistula effluent management or containment, but as an aid to wound healing. Genadyne
XLR8 Therapy is not recommended if enteric fistula effluent management or containment is the sole
goal of this therapy.
ProtectPeriwoundSkin
Consider use of a skin preparation product to protect periwound skin. Do not allow wound filler to
overlap onto intact skin. Protect fragile/friable periwound skin with additional hydrocolloid or other
transparent film.
Multiple layers of the transparent film dressing may decrease the moisture vapor transmission
rate, which may increase the risk of maceration.
If any signs of irritation or sensitivity to the film dressing, wound filler or tubing assembly
appear, discontinue use and consult a physician.
To avoid trauma to the periwound skin, do not pull or stretch the transparent film over the
wound filler dressing during film application.
Extra caution should be used for patients with neuropathic etiologies or circulatory compromise.
To Next Page
Loading...
